
Please try another search
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably test ingredients for immunoassays and quality assessment and proficiency testing controls (QAPs) that support sample collection devices. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to test for pathogens and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada.
Name | Age | Since | Title |
---|---|---|---|
Mark A. Cochran | - | 2002 | Independent Director |
Joseph D. Renner | - | 2003 | Independent Director |
Peter Martin Blecher | - | 2005 | Independent Director |
Vaughn C. Embro-Pantalony | 66 | 2007 | Independent Director |
Cameron L. Groome | - | 2012 | President, CEO & Director |
Martin A. Marino | - | 2009 | Independent Chairman of the Board |
Jennifer Stewart | - | 2022 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review